 | Up a level |
Journal Article
Evers, G., Beelen, D. W., Braess, J., Sauerland, M. C., Kolb, H. J., Reichle, A., Holler, E., Schwerdtfeger, R., Arnold, R., Scheid, C., Krug, U., Mueller-Tidow, C., Schliemann, C., Mikesch, J. -H., Lenz, G., Woermann, B. J., Hiddemann, W., Berdel, W. E. and Stelljes, M. (2018). Allogeneic hematopoietic stem cell transplantation (HSCT) beyond first complete remission (CR) in patients with acute myeloid leukemia (AML): Results from the AMLCG1999 trial. Oncol. Res. Treat., 41. S. 117 - 119. BASEL: KARGER. ISSN 2296-5262
Schulze, A. B., Evers, G., Goerlich, D., Mohr, M., Marra, A., Hillejan, L., Rehkaemper, J., Heitkoetter, B. and Schmidt, L. H. (2020). Tumor infiltrating T cells influence prognosis in stage I-III NSCLC patients. Oncol. Res. Treat., 43 (SUPPL 4). S. 138 - 139. BASEL: KARGER. ISSN 2296-5262
Schulze, A. B., Schmidt, L. H., Heitkoetter, B., Huss, S., Mohr, M., Marra, A., Hillejan, L., Goerlich, D., Barth, P. J., Rehkaemper, J. and Evers, G. (2020). CD34(+) and SMA(+) cancer-associated fibroblasts influence prognosis in stage I-III NSCLC patients. Oncol. Res. Treat., 43 (SUPPL 4). S. 144 - 145. BASEL: KARGER. ISSN 2296-5262